Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects

Status:
Completed

Trial end date:
2021-07-20

Target enrollment:

Participant gender:

The purpose of the study is to investigate how the body absorbs and get rid of eptinezumab when given directly into a vein in Chinese subjects.

Phase 1

H. Lundbeck A/S